���ϳԹ���Դ

• Early Autoimmunity
• Autoimmune Mechanisms in Addison’s Disease
• Genetic Studies on Addison’s Disease
• Autoimmune Polyendocrine Syndrome Type 1 (APS-1)
• Ultradian Rhythms and Hormonal Regulation
• Improved Treatment Strategies for Addison’s Disease
• Primary Hypoaldosteronism
• Autonomous Cortisol Secretion – A Cause of Metabolic Syndrome?
• Premature Ovarian Failure
• Autoimmune Thyroid Disease
• Registry-Based Studies on Addison’s Disease (Mortality and Crises)
• The Cortad Drug Study

Incidental finding of an adrenal tumor or thickening of the adrenal cortex is a common finding in imaging (CT and NMR) for unrelated problems. Theser are called adrenal incidentalomas and is found in around 5% of the adult population. Studies have shown that 5-30% of patients with incidentalomas have an eleveated secretion of the stress hormone cortisol foom the adrenals, knowns as autonomous cortisol secretion (ACS).

The degree of cortisol overproduction varies from lightly elevated to fulminant disease - also called Cushings syndrome. There is association between cortisol overproduction in ACS and metabolic complications such as elevated blood pressure, type 2 diabetes, overweight and osteoporosis. Several studies have also shown an increase in cardiovascular diseases and cardiovascular related deaths in this patient group.

ACS diagnostics is difficult, as the diagnostic tests available have a high degree of uncertainty giving both false positive and false negative results. As such several tests has to be perfomed, sometimes even repeating the same test several times before a diagnosis can be confirmed or disproved. Today the diagnostics is mainly based on blood samples and dynamic adrenal testing, however going forwards steroid profiling (simultaneous measurements of precursors and metabolites of cortisolsynthesis) of blood and urine, and genetic analysis will be important additions of the examination.

Our knowledge of the implications of the long term effects of mild ACS is limited, as there are few studies with long term structured follow up of these patients. Cortisol has several effects on both gene expression and inflammation processes. Biopsies of fat with genetic evaluation and studies of inflammationmarkers in ACS patients compared with healthy controls will improve our understanding of the condition on a cellular level.

Treatmen of the condition is up for debate and usually there is a individual evaluation based on the patients own wishes and the metabolic complications. The treatment options are to surgically remove one or both of the adrenals, alternatively to monitor conservatively and treat only complications of the disease (intensive monitoring of blood pressure, glucose levels and hypercholesterolemi, and possibly wheight reduction).

Principal investigator: Grethe Ueland

Primary hyperaldosteronism is caused by overproduction of the hormone aldosterone from one or both adrenal glands, leading to elevated blood pressure. Primary hyperaldosteronism is the most common form of secondary hypertension, meaning elevated blood pressure with an underlying cause. The estimated prevalence is 5-15% of all people with hypertension. Untreated primary hyperaldosteronism carries a higher risk of cardiovascular and kidney complications than primary hypertension. Therefore, it is very important to get a correct diagnosis to receive the best possible treatment that both lowers blood pressure and reduces the risk of complications. However, many cases remain undetected. If aldosterone overproduction from one adrenal gland is detected, traditional surgical removal of the affected adrenal gland is recommended, while lifelong treatment with specific blood pressure medications, mineralocorticoid receptor antagonists, which inhibit the action of aldosterone in the body, is recommended for aldosterone overproduction from both adrenal glands.

Current research projects:

• Diagnosis and follow-up of primary hyperaldosteronism

This is an observational study that has included patients with primary hyperaldosteronism who are being investigated at Haukeland University Hospital since 2013. Today's investigation of primary hyperaldosteronism is resource-intensive and consists of many steps, often with medication adjustments beforehand. The study maps the prevalence, symptoms, and findings at the time of diagnosis, as well as the results of investigation and treatment. The aim of the study is to systematize, simplify, and improve diagnostics, and provide even better treatment for PHA. We are working to expand the study to include patients with primary hyperaldosteronism who are being investigated at Oslo University Hospital.

The study has so far shown that untreated primary hyperaldosteronism leads to thickened left heart muscle (left ventricular hypertrophy) in both women and men; . The study has also shown that correct specific treatment of primary hyperaldosteronism leads to rapid improvement of thickened heart muscle and other heart damage, especially after adrenal surgery, but also with adequate doses of medical treatment. .

Results from the project are also included in international publications for improved interpretation of the investigation procedure adrenal venous catheterization, , as well as in an expected imminent publication that maps differences in time from the start of investigation to the time of adrenal surgery among centers around the world.

• Aldosterone rhythm in primary hyperaldosteronism (ULTRADIAN study)

Hormones are secreted in a rhythmic pattern, with large variations in hormone levels throughout the day. Disturbances in the secretion of aldosterone and other adrenal hormones can therefore be difficult to detect in a single blood or urine sample. In this pilot study, we have used new microdialysis technology to measure levels of adrenal hormones in subcutaneous fluid throughout the day. The purpose of the study is to increase knowledge about variations in aldosterone and other adrenal hormones' rhythmic secretion throughout the day, both in healthy individuals and in patients with primary hyperaldosteronism. This knowledge can then be used to improve diagnostics in primary hyperaldosteronism and to map treatment effects after adrenal surgery. Results from healthy controls were published in 2023; . Results from individuals with primary hyperaldosteronism have been analyzed and are expected to be published in 2025.

• Dynamic hormone profiling and multimodal data capture in primary hyperaldosteronism

This is a continuation of the ULTRADIAN study, where microdialysis technology is used to measure 24-hour hormone rhythms in tissue fluid from subcutaneous fat on the abdomen in primary hyperaldosteronism. 24-hour microdialysis can be performed in this study during diagnostic saline testing or medication use to increase knowledge about how these affect hormone rhythms. In the study, we will also map the relationship between hormone rhythms and blood pressure levels, pulse, tissue glucose, body temperature, sleep, and activity level. The study started in 2024.

Treatment with endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) compared to adrenal surgery in primary hyperaldosteronism

This is a pilot treatment study conducted at Haukeland University Hospital, where we are testing a completely new type of treatment with endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) of a lesion in the left adrenal gland, as an alternative to standard surgical treatment with removal of the entire left adrenal gland. This treatment is relevant for individuals with primary hyperaldosteronism where adrenal venous catheterization has shown lateralization of aldosterone overproduction to the left adrenal gland, as an alternative to surgery of the entire left adrenal gland. In some cases, we will also offer participation in the study to individuals where aldosterone overproduction is not clearly confined to the left adrenal gland, but where we expect that radiofrequency ablation treatment can reduce hormone overproduction and improve blood pressure. The study is conducted in close collaboration with gastroenterologists (gastrointestinal specialists) and adrenal surgeons at Haukeland University Hospital.

Primary Investigator: Marianne Grytaas

We know that the immune system of patients with Addison's disease attacks the hormone-producing cells of the adrenal cortex and that the adrenal cortex is invaded by T and B lymphocytes.

Still, we lack knowledge about why this attack is occurring. What initiates it? How are the adrenocortical cells destroyed?

As for most autoimmune diseases, Addison’s disease is presumed to be caused by a combination of genetic and environmental factors. The genetic ones are by far the best described, with most genetic risk factors identified to date being active in T and B lymphocytes.

To what target in the adrenal cortex are these lymphocytes reacting? We know that almost all patients with autoimmune Addison’s disease have antibodies directed against an enzyme almost exclusively expressed in the adrenal cortex. This enzyme is called 21-hydroxylase and plays a key role in the synthesis of vital steroid hormones like cortisol and aldosterone. Patients also have T lymphocytes recognizing this enzyme.

It is suspected that a subgroup of T lymphocytes, the so-called cytotoxic T lymphocytes, actually kills and destroys the hormone-producing cells of the adrenal cortex in a highly selective manner. For a decade, we have studied these T lymphocytes in order to detect, isolate, and characterize them. A key part of this work is identifying the specific peptides derived from 21-hydroxylase that are presented on HLA molecules and recognized by autoreactive T cells. Mapping these epitopes will help us understand the precise immune targets and may open the door to antigen-specific therapies.

If successful in understanding these mechanisms, we will not only gain increased insight into the processes leading to autoimmune Addison’s disease, but also be granted the opportunity to test new treatments and drugs targeted to halt or possibly even reverse the disease.

Perhaps this increased insight into autoimmune Addison’s disease can also be valuable for understanding other autoimmune diseases.

In a project that began in 2017 as a KG Jebsen Center collaboration between the Karolinska Institute in Stockholm and the Department of Clinical Medicine at the University of Bergen, several large-scale genetic studies are being conducted on patients with Addison’s disease. The goal is to gain deeper insight into which genetic variants increase the risk of developing Addison’s disease and why some families show a strong clustering of autoimmune disorders.

• Genome-Wide Association Studies (GWAS)

Although most of the human genome is identical from person to person, we all carry numerous small individual differences known as “variants.” Most of these variants have no biological impact, but some can increase susceptibility to diseases such as Addison’s disease. GWAS (Genome-Wide Association Study) is a method that allows researchers to analyze variants across the entire genome in a single experiment and examine how these variants are associated with traits, such as disease.

To achieve sufficient statistical power to identify new genetic risk factors, we combined the Norwegian and Swedish Addison registries through the KG Jebsen Center for Autoimmune Diseases. In the first GWAS for Addison’s disease, we compared more than 1,600 patients with 4,400 healthy controls. The initial results, received in 2018, revealed several previously unknown associations. These findings are being prepared for publication.

• Other Genetic Studies

Autoimmune diseases affect hundreds of millions of people worldwide and collectively rank among the leading causes of morbidity, chronic illness, and death. Autoimmunity targeting the thyroid gland, pancreas, gastric mucosa, and adrenal cortex accounts for more than half of all organ-specific autoimmune conditions in the U.S. and Europe. Many patients suffer from two or more of these diseases, and clustering within families is common. The prevailing theory is that most of these conditions result from the combined effects of unfavorable variants in multiple genes interacting with environmental factors. However, the genetic factors identified so far explain only a fraction of the heritability.

Much research has focused on the impact of common genetic variants—those occurring in at least 5% of the population. Our hypothesis is that the “missing heritability” is due to rare variants in individual genes, with each family carrying its own unique variant. Therefore, we have also performed comprehensive whole-genome analyses of families with a high incidence of autoimmune diseases and patients with unusually early onset of Addison’s disease. We aim to use these genetic findings to further investigate disease mechanisms and develop new diagnostic tools and personalized treatments for Addison’s disease.

Our immune system is the body’s defense against bacteria, viruses, and other foreign invaders. A key part of this defense is T cells, which patrol the body and recognize foreign substances. For the immune system to function properly, T cells must learn to distinguish between the body’s own cells and what is foreign. If they attack the body’s own organs, autoimmune disease occurs. This ability to tolerate the body’s own proteins is called immunological tolerance.

T cells mature in a small organ called the thymus, located behind the breastbone. Here, they undergo a “training round” where they learn the difference between the body’s own proteins and foreign substances. Only T cells that do not react to the body’s own proteins are allowed to enter the bloodstream.

• AIRE – The Immune System’s Teacher

A key player in this process is the protein AIRE (autoimmune regulator). AIRE acts as a “gene switch” in the thymus and turns on genes that are normally active only in specific organs, such as the pancreas or adrenal glands. For example, AIRE activates the insulin gene so that T cells can see this protein during training. If a T cell reacts to insulin, it is eliminated. In this way, AIRE prevents T cells that attack the body’s own organs from escaping into circulation.

• When AIRE Fails

If AIRE does not function, these organ-specific proteins are not displayed in the thymus. As a result, T cells that attack self-proteins can escape and trigger an autoimmune reaction. Mutations in the AIRE gene cause autoimmune polyendocrine syndrome type 1 (APS-1), a rare but serious condition. Untreated, APS-1 can lead to early death. The disease often begins with chronic fungal infections in childhood, followed by adrenal insufficiency and hypoparathyroidism. Most patients develop multiple autoimmune diseases in addition to these main features.

APS-1 is unique because mutations in a single gene can trigger widespread autoimmunity. Studies of AIRE and APS-1 have provided fundamental insights into how immunological tolerance is established—and how its breakdown leads to disease.

• New Knowledge: AIRE Dosage and Phenotype

Recent research shows that the amount of AIRE produced in the thymus can influence disease severity. Dominant mutations in AIRE can create a “dose effect,” where reduced AIRE function does not cause full APS-1 but results in a milder autoimmune phenotype with increased risk for certain diseases. This raises new questions: Can we predict disease risk based on AIRE activity? Could we one day modulate AIRE function to prevent autoimmunity?

• Our Research Project

Through our national registry, ROAS (Registry for Organ-Specific Autoimmune Diseases), we have one of the world’s largest collections of biological material from APS-1 patients. We use this to:

• Map how different AIRE mutations affect the immune system.
• Study the link between AIRE dosage and disease phenotype.
• Explore new diagnostic methods and potential treatments.

Our goal is to understand the mechanisms behind autoimmune disease—and ultimately develop personalized therapies.

Project Leader: Bergithe Eikeland Oftedal

Menopause typically occurs around the age of 50, when the ovaries reduce their production of female sex hormones, ovulation ceases, and menstruation stops. When ovarian failure occurs before the age of 40—sometimes as early as the teenage years—it is called premature ovarian insufficiency (POI). This affects about 1% of all women. The consequences can be severe, especially for women who wish to become pregnant. Hormonal changes, including reduced estrogen production, also increase the risk of conditions usually seen in older women, such as osteoporosis and cardiovascular disease.

• New Research Center

Our studies will be strengthened in the coming years through the establishment of a new Driv Research Center, funded by the University of Bergen and Trond Mohn. The center is dedicated to investigating autoimmune mechanisms underlying endocrine disorders such as Addison’s disease and premature ovarian insufficiency. It will integrate advanced genetic analyses, immunological profiling, and environmental factor mapping to uncover disease mechanisms and develop personalized treatment strategies. This initiative represents an important step toward understanding why certain families experience clustering of autoimmune diseases and how these conditions can be better diagnosed and treated.

• Causes and Consequences of Spontaneous Primary Ovarian Insufficiency

Diagnostic work-up for these women has traditionally been sporadic and limited, leaving the underlying cause unknown in most cases. By systematizing evaluation and introducing new diagnostic tools—such as NGS-based gene panel analysis, protein arrays, and environmental toxin screening—we aim to achieve higher diagnostic precision.

• Effect of Immunomodulatory Therapy on Gonadal Function

Some women with autoimmune ovarian insufficiency will be offered immunotherapy. We plan to study the effect of Rituximab, an immunomodulatory drug, in patients with autoimmune POI. By performing controlled ovarian hyperstimulation before and four months after treatment, we will investigate whether Rituximab can improve ovarian response and potentially restore ovulation and fertility.

This project is a collaboration with Karolinska Institutet in Stockholm.

• Hypogonadism in Women with Addison’s Disease

Autoimmunity affecting multiple endocrine organs is common. The prevalence of primary ovarian insufficiency is reported to be 10–20% in women with Addison’s disease and 50–70% in women with APS-1. In this study, we aim to characterize women with Addison’s disease registered in ROAS regarding prevalence of hypogonadism, type (primary/secondary, adrenal/gonadal), autoimmune status, clinical characteristics, and current medication (via prescription registry).

Project Leader: Elinor Chelsom Vogt

Here we have compiled all articles published by authors from the Endocrine Medicine Research Group, sorted by year of publishing. In addition, we highlight what we consider the group's most important contributions to the scientific field

Yael Gruper, Anette S. B. Wolff et al. Nature, 2023 Nov 22

This study shows that patients with APS-1 and coeliac disease often develop IgA autoantibodies against ameloblast-specific proteins, disrupting enamel formation and leading to a new autoimmune enamel defect.

Husebye E et al. The Lancet, 2021 Feb 13;397(10274):613-629

A comprehensive review on the diagnosis and treatment of Addison’s disease published in one of the most prestigious medical journals.

Husebye E et al. N Engl J Med, 2018; 378:1132-1141

A detailed review of autoimmune polyendocrine syndromes in the New England Journal of Medicine.

Eriksson D, Røyrvik E et al. Nature Communications, 2021

The first genome-wide association study on Addison’s disease, identifying several strong genetic signals.

Oftedal BE et al. Immunity, 2015

Shows that single mutations in AIRE predispose individuals to common autoimmune diseases like vitiligo and pernicious anemia.

Oftedal BE et al. J Clin Invest, 2023

Describes a milder APS-1 variant linked to a partially functional AIRE protein, suggesting a dose-dependent effect.

Additional Key Publications

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0::before {counter-increment: section;content: none; display: inline-block;}

• – Oftedal BE et al. Clin Immunol, 2008

Developed a diagnostic assay for APS-1 by detecting autoantibodies against interferon omega, now used clinically.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0::before {counter-increment: section;content: none; display: inline-block;}

• – Bratland E et al. J Clin Endocrinol Metab, 2009

First study to demonstrate T-cell responses against 21-hydroxylase in autoimmune adrenal insufficiency.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0::before {counter-increment: section;content: none; display: inline-block;}

• – Edvardsen K et al. J Interferon Cytokine Res, 2015

Revealed impaired innate immune responses in Addison’s patients, possibly linked to genetic variants in PTPN22.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0::before {counter-increment: section;content: none; display: inline-block;}

• – Hellesen A et al. Clin Exp Immunol, 2014

Demonstrated how adrenocortical cells may contribute to their own destruction in autoimmune Addison’s disease.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0::before {counter-increment: section;content: none; display: inline-block;}

• – Bruserud Ø et al. J Clin Endocrinol Metab, 2016

Described clinical features, autoantibody profiles, and AIRE mutations in one of the largest APS-1 cohorts.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d0::before {counter-increment: section;content: none; display: inline-block;}

• ) – Meyer S et al. Cell, 2016

Identified autoantibodies in APS-1 patients that may protect against type 1 diabetes, suggesting a novel immune role.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d1 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d1 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d1::before {counter-increment: section;content: none; display: inline-block;}

• – Meager A et al. PLoS Med, 2006

First report of interferon-targeting autoantibodies in APS-1, explaining susceptibility to viral and fungal infections.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d2 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d2 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d2::before {counter-increment: section;content: none; display: inline-block;}

• – Erichsen MM et al. J Clin Endocrinol Metab, 2009

In-depth characterization of Norwegian Addison’s patients, forming one of the best-described cohorts worldwide.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d3 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d3 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d3::before {counter-increment: section;content: none; display: inline-block;}

• – Skinningsrud B et al. J Clin Endocrinol Metab, 2011

First detailed analysis of HLA associations with Addison’s disease, identifying multiple genetic risk loci.

ol {margin-bottom:0in;margin-top:0in;}ul {margin-bottom:0in;margin-top:0in;}li {margin-top:.0in;margin-bottom:8pt;}ol.scriptor-listCounterResetlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d4 {counter-reset: section;}ol.scriptor-listCounterlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d4 {list-style-type:bullet;}li.listItemlist!list-a70f2d61-3c19-4a02-b22b-62c38afd9b6d4::before {counter-increment: section;content: none; display: inline-block;}

• – Wolff AB, Kisand K et al. J Exp Med, 2010

Explained APS-1 patients’ susceptibility to fungal infections through autoantibodies against IL-17, IL-17F, and IL-22.

1. 
   Rahman MO, Sulen A, Breivik L, Appel S, Anderson MS, Oftedal BE, Wolff ASB, Husebye ES.
   Autoimmunity. 2025 Dec;58(1):2461703. doi: 10.1080/08916934.2025.2461703. Epub 2025 Feb 19.
    
2. 
   Steintorsdottir SD, Øksnes M, Jørgensen AP, Husebye ES.
   J Clin Endocrinol Metab. 2025 Feb 18;110(3):e566-e573. doi: 10.1210/clinem/dgae822.
    
3. 
   Kvam Hellan K, Lyngstad M, Methlie P, Løvås K, Husebye ES, Ueland GÅ.
   J Clin Endocrinol Metab. 2025 Apr 22;110(5):1218-1223. doi: 10.1210/clinem/dgae486.
    
4. 
   Kucuka I, Iraji D, Braun S, Breivik L, Wolff ASB, Husebye ES, Oftedal BE.
   Scand J Immunol. 2025 Apr;101(4):e70021. doi: 10.1111/sji.70021.
    
5. 
   Fossdal G, Braadland P, Hov JR, Husebye ES, Folseraas T, Ueland PM, Ulvik A, Karlsen TH, Berge RK, Vesterhus M.Scand 
   J Gastroenterol. 2025 Feb;60(2):165-173. doi: 10.1080/00365521.2024.2447521. Epub 2025 Jan 7.
    
6. 
   Berger AH, Oftedal BE, Wolff ASB, Husebye ES, Knappskog PM, Bratland E, Johansson S.
   Front Immunol. 2025 Apr 22;16:1572789. doi: 10.3389/fimmu.2025.1572789. eCollection 2025.
    
7. 
   Steintorsdottir SD, Øksnes M, Jørgensen AP, Husebye ES. 
   J Clin Endocrinol Metab. 2025 Feb 18;110(3):e566-e573.
    
8. 
   Husebye ES, Assié G, Krone N, Achermann JC, Altieri B, Amar L, Araujo-Castro M, Brown MJ, Casey RT, Claahsen-van der Grinten HL, Davies E, Deinum J, Flück CE, Kastelan D, Kroiss M, Mulatero P, Laakso S, Pearce SH, Reincke M, Reisch N, Robledo M, Ronchi CL, Vassiliadi DA, Wiegering V, Zennaro MC.
   Horm Res Paediatr. 2025 Nov 27:1-13. doi: 10.1159/000549146
    
9. 
   Husebye ES
   JCEM Case Rep. 2025 Oct 24;3(11):luaf238. doi: 10.1210/jcemcr/luaf238
    
10. 
    Amland IM, Løvås K, Lund-Johansen M, Husebye ES, Mahesparan R, Ueland GÅ
    Tidsskr Nor Laegeforen. 2025 Aug 12;145(9)
     
11. 
    Neset MT, Nilsen RM, Løvås K, Halsøy K, Reikvam H, Stokland AM, Ueland GÅ, Wolff ASB, Aass HCD, Reppe S, Husebye ES, Rødahl E, Utheim TP, Ueland HO.
    Acta Ophthalmol. 2025 Jul 7. doi: 10.1111/aos.17556.
     
12. 
    Wolff ASB, Oftedal BE.
    Adv Exp Med Biol. 2025:1471:223-246. doi: 10.1007/978-3-031-77921-3_8.
     
13. 
    Wolff ASB, Antonelli A.
    Front Immunol. 2025 Oct 9;16:1709567. doi: 10.3389/fimmu.2025.1709567
     
14. .
    Berger AH, Oftedal BE, Wolff ASB, Husebye ES, Knappskog PM, Bratland E, Johansson S. Front Immunol. 2025 Apr 22;16:1572789. doi: 10.3389/fimmu.2025.1572789.
     
15. .
    Marek N, Wolff ASB, Dongre HN, Suliman S. 
    Front Immunol. 2025 Oct 8;16:1589553. doi: 10.3389/fimmu.2025.1589553.
     
16. 
    Islam S, Oftedal BE, Gjerdevik M, Breivik L, Røyrvik EC, Lima K, Jørgensen AP, Nwakwuo I, Skavland J, Husebye ES, Wolff ASB.
    Sci Rep. 2025 Aug 4;15(1):28398. doi: 10.1038/s41598-025-12634-y.
     
17. 
    Klaas S, Upton TJ, Zavala E, Lawton M, Bensing S, Berinder K, Botusan I, Grytaas M, Methlie P, Øksnes M, Russell G, Vassiliadi DA, Lightman SL. 
    Proc Biol Sci. 2025 Jan;292(2038):20241844. doi: 10.1098/rspb.2024.1844. 
     
18. 
    Haaverstad R, Ovrebo K, Sandvik L, Seland H, Husebø GR, Ellensen VS, Farstad M, Strandenes E, Sharma R, Øksnes M, Storesund AK, Kolseth SM. 
    J Cardiothorac Surg. 2025 Jan 11;20(1):61. doi: 10.1186/s13019-024-03287-5. 

1.  
   Beuschlein F, Else T, Bancos I, Hahner S, Hamidi O, van Hulsteijn L, Husebye ES, Karavitaki N, Prete A, Vaidya A, Yedinak C, Dekkers OM.
   Co-published in JCEM and EJE,  Volume 215, Issue 1, January 2024, Pages 47–57,
    
2. 
   Kvam Hellan K, Lyngstad M, Methlie P, Løvås K, Husebye ES, Ueland GÅ.
   J Clin Endocrinol Metab. 2024 Jul 12:dgae486. doi: 10.1210/clinem/dgae486
    
3. 
   Ueland GÅ, Ueland HO, Stokland AM, Bhan A, Schønberg A, Sollid ST, Morgas DE, Holmøy T, Lima K, Methlie P, Løvås K, Torkildsen Ø, Husebye ES.
   J Clin Endocrinol Metab. 2024 Jan 18;109(2):344-350
    
4. 
   Astor MC, Løvås K, Methlie P, Simunkova K, Assmus J, Husebye ES.
   Eur J Endocrinol. 2024 Aug 30;191(3):271-278. doi: 10.1093/ejendo/lvae102.
    
5. . Haydee Artaza, Ksenia Lavrichenko, Anette S.B. Wolff, Ellen C. Røyrvik, Marc Vaudel, Stefan Johansson.
   BMC Bioinformatics 25, 357 (2024). https://doi.org/10.1186/s12859-024-05979-0
    
6. .
   Hetemäki, Iivo; Heikkilä, Nelli; Peterson, Pärt; Kekäläinen, Eliisa; Willcox, Nick; Wolff, Anette Susanne Bøe; Jarva, H.; Arstila, Petteri.
   APMIS. 2024; 132: 881–887. IF: 3.4. http://doi.org/10.1111/apm.13458
    
7. 
   Haydee Artazaa, Daniel Eriksson, Ksenia Lavrichenko, Eirik Bratland, Marc Vaudel, Per Knappskog, Sophie Bensing, Maribel Aranda-Guillén, Sophie Bensing, Anette S.B. Wolff, Olle Kämpe, Ellen Røyrvik, Stefan Johansson.
   Front. Immunol. 2024; 15:1374499. doi: 10.3389/fimmu.2024.1374499. IF 7.3.
    
8. . 
   Thea Sjøgren, Shahinul Islam#, Igor Filippov#, Adrianna Jebrzycka, André Sulen, Lars E. Breivik, Alexander Hellesen, Anders P. Jørgensen, Kari Lima, Liina Tserel, Kai Kisand, Pärt Peterson, Annamari Ranki, Eystein S. Husebye, Bergithe E. Oftedal, Anette S. B. Wolff.
   iScience 27, 109610 April 19, 2024. IF 5.8. DOI: 10.1016/j.isci.2024.109610
    
9. 
   Bergithe E. Oftedal, Thea Sjøgren and Anette S. B. Wolff (*). Review. 
   Front Immunol. 2024 Feb 22;15:1327784. doi: 10.3389/fimmu.2024.1327784. IF 7.3.
    
10. 
    Thea Sjøgren, Jan-Inge Bjune, Eystein S. Husebye, Bergithe E. Oftedal, Anette S. B. Wolff (*).
    Clin Exp Immunol. 2024 Jan; 215(1): 47–57. DOI: 10.1093/cei/uxad087 (*). IF 4.6.

1. 
   Bergithe Eikeland Oftedal, Amund Holte Berger#, Øyvind Bruserud, Yael Goldfarb, Andre Sulen, Lars Breivik, Alexander Hellesen, Shifra Ben-Dor, Rebecca Haffner-Krausz, Per Knappskog, Stefan Johansson, Anette Bøe Wolff, Eirik Bratland, Jakub Abramson, Eystein Sverre Husebye. 
   Journal of clinical investigation. 2023 Nov 1; 133(21):
    
2. 
   Yael Gruper, Anette S. B. Wolff, Liad Glanz, Frantisek Spoutil, Mihaela Cuida Marthinussen, Adriana Osičková, Yonatan Herzig, Yael Goldfarb, Goretti Aranaz-Novaliches, Jan Dobeš, Noam Kadouri, Osher Ben-Nun, Amit Binyamin, Bar Lavi, Tal Givony, Razi Khalaila, Tom Gome, Tomáš Wald, Blanka Mrazkova, Carmel Sochen, Marine Besnard, Shifra Ben-Dor, Ester Feldmesser, Elisaveta M. Orlova, Csaba Hegedűs, István Lampé, Tamás Papp, Szabolcs Felszeghy, Radislav Sedlacek, Esti Davidovich, Noa Tal, Dror S. Shouval, Raanan Shamir, Carole Guillonneau, Zsuzsa Szondy, Knut E. A. Lundin, Radim Osička, Jan Prochazka, Eystein S. Husebye, & Jakub Abramson
   Nature. 2023 Nov 22
    
3. 
   Elinor Chelsom Vogt, Eirik Bratland, Siren Berland, Ragnhild Berentsen, Agnethe Lund, Sigridur Björnsdottir, Eystein Husebye, Marianne Øksnes
   Hum Reprod. 2023 Nov 9:dead233.
    
4. 
   Anette S B Wolff, Lena Hansen, Marianne Aa Grytaas, Bergithe E Oftedal, Lars Breivik, Fan Zhou, Karl Ove Hufthammer, Thea Sjøgren, Jan Stefan Olofsson, Mai Chi Trieu, Anthony Meager, Anders P Jørgensen, Kari Lima, Kristin Greve-Isdahl Mohn, Nina Langeland, Rebecca Jane Cox, Eystein S Husebye
   iScience. 2023 Jul 21;26(7):107084. doi: 10.1016/j.isci.2023.107084. Epub 2023 Jun 9.
    
5. 
   Grethe Å Ueland, Paal Methlie, Anette Heie, Ann-Elin Meling Stokland, Anne Lise Dahle, Åse B Sævik, Kristian Løvås, Eystein S Husebye
   Eur J Endocrinol . 2023 Jul 20;189(1):78-86. doi: 10.1093/ejendo/lvad076.
    
6. 
   Marianne Øksnes, Eystein S Husebye
   J Clin Endocrinol Metab . 2023 Jul 14:dgad402. doi: 10.1210/clinem/dgad402.
    
7. 
   Ann-Elin Meling Stokland, Marie Austdal, Bjørn Gunnar Nedrebø, Siri Carlsen, Hanne Brit Hetland, Lars Breivik, Hans Olav Ueland, Torquil Watt, Per Karkov Cramon, Kristian Løvås, Eystein Sverre Husebye, Grethe Åstrøm Ueland
   J Clin Endocrinol Metab. 2023 Sep 25:dgad538. doi: 10.1210/clinem/dgad538.
    
8. 
   Aranda-Guillén M, Røyrvik EC, Fletcher-Sandersjöö S, Artaza H, Botusan IR, Grytaas MA, Hallgren Å, Breivik L, Pettersson M, Jørgensen AP, Lindstrand A, Vogt E; Norwegian Addison Registry Study Group, The Swedish Addison Registry Study Group; Husebye ES, Kämpe O, Wolff ASB, Bensing S, Johansson S, Eriksson D.
   J Intern Med. 2023 May 8. doi: 10.1111/joim.13649.
    
9. 
   Grethe Åstrøm Ueland, Hans Olav Ueland, Ann-Elin Meling Stokland, Alok Bhan, Anne Schønberg, Stina T Sollid, Dina Edvarda Morgas , Trygve Holmøy, Kari Lima, Paal Methlie, Kristian Løvås, Øivind Torkildsen, Eystein S Husebye  
   J Clin Endocrinol Metab.  Sep :dgad.
    
10. 
    Bergithe E Oftedal, Kristian Assing, Safa Baris, Stephanie L Safgren, Isik S Johansen, Marianne Antonius Jakobsen, Dusica Babovic-Vuksanovic, Katherine Agre, Eric W Klee, Emina Majcic , Elise M N Ferré , Monica M Schmitt, Tom DiMaggio, Lindsey B Rosen , Muhammad Obaidur Rahman, Dionisios Chrysis, Aristeidis Giannakopoulos , Maria Tallon Garcia, Luis Ignacio González-Granado, Katherine Stanley, Jessica Galant-Swafford, Pim Suwannarat, Isabelle Meyts, Michail S Lionakis, Eystein S Husebye
    iScience. 2023 May 5;26(6):106818.
     
11. 
    Oftedal BE, Delaleu N, Dolan D, Meager A, Husebye ES, Wolff ASB.
    FEBS Lett. 2023 May;597(9):1261-1274. doi: 10.1002/1873-3468.14625.
     
12. 
    Ueland HO, Ulvik A, Løvås K, Wolff ASB, Breivik LE, Meling Stokland AE, Rødahl E, Nilsen RM, Husebye E, Ueland GÅ.
    J Clin Endocrinol Metab. 2023 Jan 6
     
13. 
    Öster S, Esposito D, Aranda-Guillén M, Åkerman AK, Wahlberg J, Husebye ES, Kämpe O, Botusan IR, Dahlqvist P, Bergthorsdottir R, Bensing S.
    Eur J Endocrinol. 2023 Jan 31
     
14. 
    Nowotny HF, Bryce J, Ali SR, Giordano R, Baronio F, Chifu I, Tschaidse L, Cools M, Van den Akker ELT, Falhammar H, Appelman-Dijkstra NM, Persani L, Beccuti G, Ross IL, Grozinsky-Glasberg S, Pereira AM, Husebye ES, Hahner S, Ahmed SF, Reisch N.
    Endocr Connect. 2023 Jan 1:EC-22-0416.
     
15.  
    Mandel-Brehm C, Vazquez SE, Liverman C, Cheng M, Quandt Z, Kung AF, Parent A, Miao B, Disse E, Cugnet-Anceau C, Dalle S, Orlova E, Frolova E, Alba D, Michels A, Oftedal BE, Lionakis MS, Husebye ES, Agarwal AK, Li X, Zhu C, Li Q, Oral E, Brown R, Anderson MS, Garg A, DeRisi JL.
    Diabetes. 2023 Jan 1;72(1):59-70.
     
16. 
    Simunkova K, Løvås K, Methlie P, Jovanovic N, Bifulco E, Bronstad I, Lightman SL, Husebye ES, Oksnes M.
    Horm Metab Res. 2023 May 12. doi: 10.1055/a-2092-5228
     
17. 
    Anna-Karin Åkerman, Åse Bjorvatn Sævik, Per Medbøe Thorsby, Paal Methlie, Marcus Quinkler, Anders Palmstrøm Jørgensen, Charlotte Höybye, Aleksandra J. Debowska, Bjørn Gunnar Nedrebø, Anne Lise Dahle, Siri Carlsen, Aneta Tomkowicz, Stina Therese Sollid, Ingrid Nermoen, Kaja Grønning, Per Dahlqvist, Guri Grimnes, Jakob Skov, Trine Finnes, Jeanette Wahlberg,
    Synnøve Emblem Holte, Katerina Simunkova, Olle Kämpe, Eystein Sverre Husebye, Marianne Øksnes and Sophie Bensing
    J. Clin. Med. 2023, 12(10), 3602
     
18.  
    Dorsa Iraji, Bergithe E.Oftedal, Anette S. B. Wolff
    Critical reviews in immunology. DOI 10.1615/CritRevImmunol.2023050360.
     
19. 
    Anette S. B. Wolff, Isil Kucuka and Bergithe E. Oftedal
    Frontiers Endocrinology. 2023 Nov Volume 14 - 2023
     
20. 
    Grytaas MA, Løvås K.
    J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1745-e1746
     
21. 
    Lejlic S, Holmaas G, Løvås K, Ueland GÅ.
    Tidsskr Nor Laegeforen. 2023 Feb 20;143(3).
     
22. 
    Naruse M, Murakami M, Katabami T, Kocjan T, Parasiliti-Caprino M, Quinkler M, St-Jean M, O'Toole S, Ceccato F, Kraljevic I, Kastelan D, Tsuiki M, Deinum J, Torre EM, Puar T, Markou A, Piaditis G, Laycock K, Wada N, Grytaas MA, Kobayashi H, Tanabe A, Tong CV, Gallego NV, Gruber S, Beuschlein F, Kürzinger L, Sukor N, Azizan EABA, Ragnarsson O, Nijhoff MF, Maiolino G, Dalmazi GD, Kalugina V, Lacroix A, Furnica RM, Suzuki T
    Eur J Endocrinol. 2023 Jan 10;188(1):lvac002
     
23. 
    Aune A, Gerdts E, Kokorina M, Kringeland E, Midtbø H, Løvås K, Grytaas MA.
    J Hypertens. 2022 Jun 1;40(6):1204-1211
     
24. 
    Prete A, Subramanian A, Bancos I, Chortis V, Tsagarakis S, Lang K, Macech M, Delivanis DA, Pupovac ID, Reimondo G, Marina LV, Deutschbein T, Balomenaki M, O'Reilly MW, Gilligan LC, Jenkinson C, Bednarczuk T, Zhang CD, Dusek T, Diamantopoulos A, Asia M, Kondracka A, Li D, Masjkur JR, Quinkler M, Ueland GÅ, Dennedy MC, Beuschlein F, Tabarin A, Fassnacht M, Ivović M, Terzolo M, Kastelan D, Young WF Jr, Manolopoulos KN, Ambroziak U, Vassiliadi DA, Taylor AE, Sitch AJ, Nirantharakumar K, Arlt W; ENSAT EURINE-ACT Investigators*; ENSAT EURINE-ACT Investigators.
    Ann Intern Med. 2022 Mar;175(3):325-334.
     
25. 
    Ueland HO, Neset MT, Methlie P, Ueland GÅ, Pakdel F, Rødahl E.
    Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S19-S28.
     
26. 
    Hernar I, Cooper JG, Nilsen RM, Skinner TC, Strandberg RB, Iversen MM, Graue M, Ernes T, Løvaas KF, Madsen TV, Lie SS, Richards DA, Ueland GÅ, Haugstvedt A.
    Diabetes Care. 2023 Nov 3:dc231001.
     
27. 
    Vonheim Madsen T, Cooper JG, Carlsen S, Loevaas K, Rekdal M, Igland J, Sandberg S, Ueland GÅ, Iversen MM, Sølvik U.
    BMJ Open Qual. 2023 Jun;12(2):e002099
     
28. 
    Nilsen A, Thorsnes A, Lie SA, Methlie P, Bunaes DF, Reinholtsen KK, Leknes KN.
    BMC Oral Health. 2023 Jul 1;23(1):439.

1. 
   Sjøgren T, Bratland E, Røyrvik EC, Grytaas MA, Benneche A, Knappskog PM, Kämpe O, Oftedal BE, Husebye ES, Wolff ASB.
   J Autoimmun. 2022 Sep 30;133:102917
    
2. 
   Husebye ES, Castinetti F, Criseno S, Curigliano G, Decallonne B, Fleseriu M, Higham CE, Lupi I, Paschou SA, Toth M, van der Kooij M, Dekkers OM.
   Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21.
    
3.  
   Nowotny H, Neumann U, Tardy-Guidollet V, Ahmed SF, Baronio F, Battelino T, Bertherat J, Blankenstein O, Bonomi M, Bouvattier C, Brac de la Perrière A, Brucker S, Cappa M, Chanson P, Claahsen-van der Grinten HL, Colao A, Cools M, Davies JH, Dörr HG, Fenske WK, Ghigo E, Giordano R, Gravholt CH, Huebner A, Husebye ES, Igbokwe R, Juul A, Kiefer FW, Léger J, Menassa R, Meyer G, Neocleous V, Phylactou LA, Rohayem J, Russo G, Scaroni C, Touraine P, Unger N, Vojtková J, Yeste D, Lajic S, Reisch N.
   Eur J Endocrinol. 2022 Mar 23;186(5):K17-K24
    
4.  
   Ueland GÅ, Dahl SR, Methlie P, Hessen S, Husebye ES, Thorsby PM.
   Fertil Steril. 2022 Aug;118(2):384-391.
    
5.  
   Saila Laakso, Elina Holopainen, Corrado Betterle, Viivi Saari, Elinor Vogt, Monica M Schmitt, Karen K Winer, Maria Kareva, Chiara Sabbadin, Eystein S Husebye, Elizaveta Orlova, Michail S Lionakis and Outi Mäkitie.
   J Clin Endocrinol Metab. 2022 Feb; 107(2): e528–e537
    
6. 
   Røyrvik EC, Husebye ES.
   Nat Rev Endocrinol. 2022 Jul;18(7):399-412
    
7. 
   Ueland HO, Ueland GÅ, Løvås K, Breivik LE, Thrane AS, Meling Stokland AE, Rødahl E, Husebye ES.
   Eur J Endocrinol. 2022 Jun 29;187(2):293-300.
    
8. 
   Ann-Elin Meling Stokland, Grethe Ueland, Kari Lima, Kaja Grønning, Trine E Finnes, Margrethe Svendsen, Aneta Ewa Tomkowicz, Synnøve Emblem Holte, Stina Therese Sollid, Aleksandra Debowska, Hallvard Singsås, Marthe Landsverk Rensvik, Helle Lejon, Dag-Erik Sørmo, Anders Svare, Sigrid Blika, Petya Milova, Elin Korsgaard, Øystein Husby, Lars Breivik, Anders P Jørgensen, Eystein Sverre Husebye.
   J Clin Endocrinol Metab. 107 (6), e2331-e2338
    
9. 
   Mandel-Brehm C, Vazquez SE, Liverman C, Cheng M, Quandt Z, Kung AF, Parent A, Miao B, Disse E, Cugnet-Anceau C, Dalle S, Orlova E, Frolova E, Alba D, Michels A, Oftedal BE, Lionakis MS, Husebye ES, Agarwal AK, Li X, Zhu C, Li Q, Oral E, Brown R, Anderson MS, Garg A, DeRisi JL.
   Diabetes. 2022 Jun 16:db211172.
    
10. 
    Vogt EC, Real FG, Husebye ES, Björnsdottir S, Benediktsdottir B, Bertelsen RJ, Demoly P, Franklin KA, de Aja Gallastegui LS, González FJC, Heinrich J, Holm M, Jogi NO, Leynaert B, Lindberg E, Malinovschi A, Martínez-Moratalla J, Mayoral RG, Oudin A, Pereira-Vega A, Semjen CR, Schlünssen V, Triebner K, Øksnes M.
    Endocr Connect. 2022 May 25;11(5)
     
11. 
    Ueland GÅ, Ernes T, Vonheim Madsen T, Husebye ES, Sandberg S, Fjell Løvaas K, Cooper JG.
    PLoS One. 2022 Jul 28;17(7):e0272133
     
12. 
    Dobeš J, Ben-Nun O, Binyamin A, Stoler-Barak L, Oftedal BE, Goldfarb Y, Kadouri N, Gruper Y, Givony T, Zalayat I, Kováčová K, Böhmová H, Valter E, Shulman Z, Filipp D, Husebye ES, Abramson
    J.Nat Immunol. 2022 Jul;23(7):1098-1108. 
     
13. 
    Johan G Beun, Pia Burman, Olle Kämpe, Eystein S Husebye, Stephanie Hahner, Jette Kristensen, Alida Noordzij, and Per Dahlqvist
    Endocr Connect. 2022 Dec 12;12(1)
     

1. 
   Alexander Hellesen, Sigrid Aslaksen, Lars Breivik, Ellen Christine Røyrvik, Øyvind Bruserud, Kine Edvardsen, Karl Albert Brokstad, Anette Susanne Bøe Wolff, Eystein Sverre Husebye and Eirik Bratland
   Front. Immunol. 2021 Oct, 12:742848
    
2. 
   Paul Bastard, Elizaveta Orlova, Leila Sozaeva, Romain Levy , Alyssa James, Monica M. Schmitt , Sebastian Ochoa, Maria Kareva , Yulia Rodina , Adrian Gervais,, Tom Le Voyer, Jeremie Rosain, Quentin Philippot, Anna-Lena Neehus, Elana Shaw, Melanie Migaud, Lucy Bizien, Olov Ekwal,, Stefan Berg, Guglielmo Beccuti0, Lucia Ghizzoni0, Gerard Thiriez, Arthur Pavot, Cecile Goujard, Marie-Louise Fremond, Edwin Carter, Anya Rothenbuhler, Agnès Linglart, Brigite Mignot, Aurelie Comte, Nathalie Cheikh, Olivier Hermine,, Lars Breivik, Eystein S. Husebye, Sebastien Humbert, Pierre Rohrlich, Alain Coaquette, Fanny Vuoto, Karine Faure, Nizar Mahlaoui, Primoz Kotnik, Tadej Battelino,, Katarina Trebusak Podkrajsek, Kai Kisand, Elise M.N. Ferre, Thomas DiMaggio, Lindsey B. Rosen, Peter D. Burbelo, Martin McIntyre, Nelli Y. Kann , Anna Shcherbina, Maria Pavlova, Anna Kolodkina, Steven M. Holland, Shen-Ying Zhang, Yanick J. Crow,, Luigi D. Notarangelo , Helen C. Su , Laurent Abel, Mark S. Anderson, Emmanuelle Jouanguy, Benedicte Neven, Anne Puel, Jean-Laurent Casanova and Michail S. Lionakis
   J Exp Med (2021) 218 (7): e20210554.
    
3. .
   Anette Boe Wolff, Lars Breivik, Karl Ove Hufthammer, Marianne Aardal Grytaas, Eirik Bratland, Eystein Sverre Husebye and Bergithe Eikeland Oftedal
   European Journal of Endocrinology (2021) 184, 607–615
    
4. 
   Daniel Eriksson, Ellen Christine Røyrvik, Maribel Aranda-Guillén, Amund Holte Berger, Nils Landegren, Haydee Artaza Alvarez, Åsa Hallgren, Marianne Grytaas, Sara Ström, Eirik Bratland, Ileana Botusan, Bergithe Eikeland Oftedal, Lars Breivik, Marc Vaudel, Øyvind Helgeland, Alberto Falorni, Anders P. Jørgensen, Anna-Lena Hulting, Johan Svartberg, Olov Ekwall, Kristian Fougner, Jeanette Wahlberg, Bjørn G. Nedrebø, Per Dahlqvist, The Norwegian Addison Registry Study Group, The Swedish Addison Registry Study Group, Per Morten Knappskog, Anette Susanne Bøe Wolff, Sophie Bensing, Stefan Johansson, Olle Kämpe, Eystein S. Husebye. Nature Communications, 2021 Feb 11;12(1):959. doi: 10.1038/s41467-021-21015-8.
    
5. 
   Eystein S. Husebye, Simon Pearce, Nils Krone, Olle Kämpe.
   The Lancet, 2021 Feb 13;397(10274):613-629
    
6. 
   Goldfarb Y, Givony T, Kadouri N, Dobeš J, Peligero-Cruz C, Zalayat I, Damari G, Dassa B, Ben-Dor S, Gruper Y, Oftedal BE, Bratland E, Erichsen MM, Berger A, Avin A, Nevo S, Haljasorg U, Kuperman Y, Ulman A, Haffner-Krausz R, Porat Z, Atasoy U, Leshkowitz D, Husebye ES, Abramson J.
   J Exp Med. 2021 Nov 1;218(11):e20201076.
    
7. 
   Wolff ASB, Braun S, Husebye ES, Oftedal BE.
   Biomedicines. 2021 Sep 21;9(9):1274.
    
8.  
   Åse Bjorvatn Sævik, Anette B Wolff, Sigridur Björnsdottir, Katerina Simunkova, Martha Schei Hynne, David William Peter Dolan, Eirik Bratland, Per M Knappskog, Paal Methlie, Siri Carlsen, Magnus Isaksson, Sophie Bensing, Olle Kämpe, Eystein S Husebye, Kristian Løvås, Marianne Øksnes.
   Journal of the Endocrine Society, Volume 5, Issue 3, March 2021, bvaa202
    
9. 
   Hahner S, Ross RJ, Arlt W, Bancos I, Burger-Stritt S, Torpy DJ, Husebye ES, Quinkler M.
   Nat Rev Dis Primers. 2021 Mar 11;7(1):19
    
10. 
    Vogt EC, Breivik L, Røyrvik EC, Grytaas M, Husebye ES, Øksnes M.
    J Clin Endocrinol Metab. 2021 Mar 4:dgab14
     
11. 
    Marissa Penna-Martinez, Gesine Meyer, Anette Bøe Wolff, Beate Skinningsrud, Corrado Betterle, Alberto Falorni, William Ollier, Dag Undlien, Eystein Husebye, Simon Pearce, Anna L Mitchell and Klaus Badenhoop.
    Eur J Endocrinol. 2021 Mar;184(3):373-381.
     
12. 
    Nora Møller Didriksen, Åse Bjorvatn Sævik, Linn Solveig Sortland, Marianne Øksnes, Eystein Sverre Husebye
    Front Endocrinol (Lausanne). 2021 Oct 18;12:718660.
     
13. 
    Berger, Amund Holte; Bratland, Eirik; Sjøgren, Thea; Heimli, Marte; Tyssedal, Torgeir; Bruserud, Øyvind; Johansson, Stefan; Husebye, Eystein Sverre; Oftedal, Bergithe Eikeland; Wolff, Anette Susanne Bøe.
    Frontiers in Immunology 2021 ;Volum 12
     
14. 
    Elinor Chelsom Vogt, Kathrin Hammerling, Halfdan Sorbye, Anette Heie, Andre Sulen, Grethe Ueland, Eystein Husebye, and Paal Methlie.
    Endocrinology, Diabetes & Metabolism Case Reports Issiue, Vol:21-01; November 2021

1. 
   Paul Bastard, Lindsey B. Rosen, Qian Zhang...Eystein S. Husebye…Jean-Laurent Casanova.
   Science 370, eabd4585 (2020). DOI: 10.1126/science.abd4585
    
2. 
   Sævik ÅB, Åkerman, AK, Methlie P, Quinkler M, Jørgensen AP, Höybye C, Debowska AJ, Nedrebø BG, Dahle AL, Carlsen S, Tomkowicz A, Sollid ST, Nermoen I, Grønning K, Dahlqvist P, Grimnes G, Skov J, Finnes T, Valland SF, Wahlberg J, Holte SE, Simunkova K, Kämpe O, Husebye ES, Bensing S, Øksnes M
   J Clin Endocrinol Metab, Volume 105, Issue 7, July 2020, Pages 2430–2441
    
3. 
   Grønning K, Sharma A, Mastroianni MA, Karlsson BD, Husebye ES, Løvås K, Nermoen I.
   Endocrinol Diabetes Metab Case Rep 2020 Mar 10;2020:19-0131. doi: 10.1530/EDM-19-0131
    
4. 
   Christina Bothou, Gurpreet Anand, Dingfeng Li, Tina Kienitz, Khyatisha Seejore, Chiara Simeoli, Andreas Ebbehoj, Emma G Ward, Rosa Maria Paragliola, Rosario Ferrigno, Klaus Badenhoop, Sophie Bensing, Marianne Oksnes, Daniela Esposito, Ragnhildur Bergthorsdottir, William Drake, Jeanette Wahlberg, Nicole Reisch, Stefanie Hahner, Simon Pearce, Peter Trainer, Gwendolin Etzrodt-Walter, Sébastien P Thalmann, Åse B Sævik, Eystein Husebye, Andrea M Isidori, Henrik Falhammar, Gesine Meyer, Salvatore M Corsello, Rosario Pivonello, Robert Murray, Irina Bancos, Marcus Quinkler, Felix Beuschlein
   J Clin Endocrinol Metab, Volume 105, Issue 8, August 2020.
    
5. 
   Grethe Å Ueland, Thea Grinde, Paal Methlie, Oskar Kelp, Kristian Løvås, Eystein S Husebye
   Endocr Connect. 2020 Oct;9(10):963-970. 
    
6. 
   Bergithe Eikeland Oftedal and Anette Susanne Bøe Wolff
   Scand J Immunol. 2020 Nov;92(5):e12961
    
7. 
   André Sulen, Shahinul Islam, Anette S B Wolff, Bergithe E Oftedal
   Scand J Immunol. 2020 Nov;92(5):e12964.
    
8. 
   Marianne Aardal Grytaas, Lars Breivik, Anders Palmstrøm Jørgensen, Trine Elisabeth Finnes, Lena Adriana Denstad Skavlan, Robert Wiik, Knut Ivar Johansen, Eystein Sverre Husebye
   Tidsskr Nor Legeforen 2020 Utgave 14, 13. oktober 2020
    
9. 
   Anne-Lise Bjørke Monsen, Solveig Meyer Mikalsen, Grethe Åstrøm Ueland, Jan Aaseth og Jon Elling Whist
   Clinical Nutrition ESPEN Volume 41, February 2021, Pages 405-411

Astor MC, Zhu W, Björnsdottir S, Bollerslev J, Kämpe O, Husebye ES
J Intern Med 2019 Apr;285(4):429-435. Epub 2018 des 12

Eriksson D, Bacchetta R, Gunnarsson HI, Chan A, Barzaghi F, Ehl S, Hallgren Å, van Gool F, Sardh F, Lundqvist C, Laakso SM, Rönnblom A, Ekwall O, Mäkitie O, Bensing S, Husebye ES, Anderson M, Kämpe O, Landegren N
J Allergy Clin Immunol 2019 Jul;144(1):327-330.e8. Epub 2019 apr 23

Sigrid Aslaksen, Anette B.Wolff, Magnus D. Vigeland, Lars Breivik, Ying Shen, Bergithe E.Oftedal, Haydee Artaza, Beate Skinningsrud, Dag E. Undlien, Kaja K.Selmer, Eystein S.Husebye, Eirik Bratland
Journal of Translational Autoimmunity, 2019

Aslaksen S, Methlie P, Vigeland MD, Jøssang DE, Wolff AB, Sheng Y, Oftedal BE, Skinningsrud B, Undlien DE, Selmer KK, Husebye ES, Bratland E
Front Endocrinol (Lausanne) 2019;10():648. Epub 2019 sep 27

Berglund A, Cleemann L, Oftedal BE, Holm K, Husebye ES, Gravholt CH.
Clin Exp Immunol. 2019;195(3):364-368. doi:10.1111/cei.13231

Ueland GÅ, Methlie P, Øksnes M, Thordarson HB, Sagen J, Kellmann R, Mellgren G, Ræder M, Dahlqvist P, Dahl SR, Thorsby PM, Løvås K, Husebye ES
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1696-1703

Bruserud Ø, Siddiqui H, Marthinussen MC, Chen T, Jonsson R, Oftedal BE, Olsen I, Husebye ES, Wolff AB
JOral Microbiol. 2018 Feb 26;10(1)

Hellesen A, Bratland E, Husebye ES
Ann Endocrinol (Paris). 2018 Jun;79(3):157-163

Ueland GA, Husebye ES.
Front Horm Res. 2018;49:104-113.

Ueland GÅ, Methlie P, Jøssang DE, Sagen JV, Viste K, Thordarson HB, Heie A, Grytaas M, Løvås K, Biermann M, Husebye ES
JClin Endocrinol Metab. 2018 Aug 2.

 
Bruserud Ø, Costea DE, Laakso S, Garty BZ, Mathisen E, Mäkitie A, Mäkitie O, and Eystein S. Husebye
Front Endocrinol. 2018 Aug 17;9:463

 
Husebye ES, Anderson MS, Kämpe O.
N Engl J Med 2018; 378:1132-1141. doi : 10.1056/NEJMra1713301

Eriksson D, Dalin F Eriksson GN, Landegren N, Bianchi M, Hallgren Å, Dahlqvist P, Wahlberg J, Ekwall O, Winqvist O, Catrina SB, Rönnelid J; Swedish Addison Registry Study Group, Hulting AL, Lindblad-Toh K, Alimohammadi M, Husebye ES, Knappskog PM, Rosengren Pielberg G, Bensing S, Kämpe O.
J Clin Endocrinol Metab. 2018 Jan 1;103(1):179-186. doi: 10.1210/jc.2017-01957.

.
Bremer HD, Landegren N, Sjöberg R, Hallgren Å, Renneker S, Lattwein E, Leonard D, Eloranta ML, Rönnblom L, Nordmark G, Nilsson P, Andersson G, Lilliehöök I, Lindblad-Toh K, Kämpe O, Hansson-Hamlin
H.Sci Rep. 2018 Mar 19;8(1):4852. doi: 10.1038/s41598-018-23034-w.

 
Hellesen A, Bratland E.
Clin Exp Immunol. 2018 Aug 24. doi: 10.1111/cei.13207.

 
Sævik ÅB, Åkerman AK, Grønning K, Nermoen I, Valland SF, Finnes TE, Isaksson M, Dahlqvist P, Bergthorsdottir R, Ekwall O, Skov J, Nedrebø BG, Hulting AL, Wahlberg J, Svartberg J, Höybye C, Bleskestad IH, Jørgensen AP, Kämpe O, Øksnes M, Bensing S, Husebye E.
J Intern Med. 2018 Feb;283(2):190-199. doi: 10.1111/joim.12699

Ueland GÅ, Methlie P, Kellmann R, Bjørgaas M, Åsvold BO, Thorstensen K, Kelp O, Thordarson HB, Mellgren G, Løvås K, Husebye ES.
Eur J Endocrinol 176, 705-713, 2017.

Fishman D, Kisand K, Hertel C, Rothe M, Remm A, Pihlap M, Adler P, Vilo J, Peet A, Meloni A, Podkrajsek KT, Battelino T, Bruserud Ø, Wolff ASB, Husebye ES, Kluger N, Krohn K, Ranki A, Peterson H, Hayday A, Peterson P.
Front Immunol 8, 976. doi: 10.3389/fimmu.2017.00976. eCollection 2017.

.
Nermoen I, Husebye ES, Myhre AG, Løvås K.
Tidsskr Nor Laegeforen 137, 540-543, 2017.

1
Smith-Anttila CJA, Bensing S, Alimohammadi M, Dalin F, Oscarson M, Zhang MD, Perheentupa J, Husebye ES, Gustafsson J, Björklund P, Fransson A, Nordmark G, Rönnblom L, Meloni A, Scott RJ, Hökfelt T, Crock PA, Kämpe O.
Autoimmunity 50, 223-231, 2017

Orlova EM, Sozaeva LS, Kareva MA, Oftedal BE, Wolff ASB, Breivik L, Zakharova EY, Ivanova ON, Kämpe O, Dedov II, Knappskog PM, Peterkova VA, and Husebye ES.
J Clin Endocrinol Metabol 102, 3546-56, 2017.

.
Grytaas MAa, Strømsøy SS, Rørvik JT, Arnes JB, Heie A, Arnesen T,  Jørstad MD, Nedrebø BG,  Jøssang DE, Jensen DK, Rørvik HD, Sagen JV, Mellgren G, Thordarson HB, Husebye ES, Løvås K.
Horm Metab Res 2017; 49(11): 838-846

Bahador M, Gras Navarro A, Rahman MA, Dominguez-Valentin M, Sarowar S, Ulvestad E, Njølstad G, Lie SA, Kristoffersen EK, Bratland E, Chekenya M. 
Oncoimmunology. 2017 Jun 5;6(8):e1336272.

Bruserud Ø, Bratland E, Hellesen A, Delaleu N, Reikvam H, Oftedal BE, Wolff ASB.
Front Immunol. 2017 Sep 1;8:1074.

I
Oftedal BE, Marthinussen MC, Erichsen MM, Tveitarås MK, Kjellesvik-Kristiansen A, Hammenfors D, Jonsson MV, Kisand K, Jonsson R, Wolff ASB.
Autoimmunity. 2017 Jun;50(4):211-222.

. Simunkova K, Jovanovic N, Rostrup E, Methlie P, Øksnes M, Nilsen RM, Hennø H, Tilseth M, Godang K, Kovac A, Løvås K, Husebye ES.
Eur J Endocrinol 174, 97-105, 2016.

Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. J Clin Endocrinol Metabol 101, 364-389, 201

1
Nils Landegren N, Sharon D, Freyhult E, Hallgren Å, Eriksson D, Edqvist PH, Bensing S, Wahlberg J, Nelson LM, Gustafsson J, Husebye ES, Anderson MS, Snyder M, Kämpe O.
Sci Rep. 2016 Feb 1;6:20104.

.
Hetemäki I, Jarva H, Kluger N, Baldauf HM, Laakso S, Bratland E, Husebye ES, Kisand K, Ranki A, Peterson P, Arstila TP.
J Immunol. 196, 2955-64, 2016.

.
Edvardsen K, Hellesen A, Husebye ES, Bratland E.
J Transl Med. 14, 68, 2016.

Landegren N, Pourmousa Lindberg M, Skov J, Hallgren Ã…, Eriksson D, Lisberg Toft-Bertelsen T, MacAulay N, Hagforsen E, Räisänen-Sokolowski A, Saha H, Nilsson T, Nordmark G, Ohlsson S, Gustafsson J, Husebye ES, Larsson E, Anderson MS, Perheentupa J, Rorsman F, Fenton RA, Kämpe O.
J Am Soc Nephrol. 2016 Oct;27(10):3220-3228.

Bensing S, Hulting AL, Husebye ES, Kämpe O, Løvås K.
Eur J Endocrinol.175, R107-116, 2016.

.
Astor MC, Løvås K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebø¸ BG, Svartberg J, Husebye ES.
J Clin Endocrinol Metab. 101, 345-354, 2016

Simunkova K, Husebye ES. 
Front Horm Res. 46, 196-210, 2016.

Bruserud Ø, Oftedal BE, Landegren N, Erichsen MM, Bratland E, Lima K, Jørgensen AP, Myhre AG, Svartberg J, Fougner KJ, Bakke Å, Nedrebø BG, Mella B, Breivik L, Viken MK, Knappskog PM, Marthinussen MC, Løvås K, Kämpe O, Wolff AB, Husebye ES.
J Clin Endocrinol Metab. 101, 2975-83, 2016.

.
Meyer S, Woodward M, Hertel C, Vlaicu P, Haque Y, Kärner J, Macagno A, Onuoha SC, Fishman D, Peterson H, Metsküla K, Uibo R, Jäntti K, Hokynar K, Wolff AS; APECED patient collaborative, Krohn K, Ranki A, Peterson P, Kisand K, Hayday A.
Cell 166, 582-95, 2016.

. Bensing S, Hulting AL, Husebye ES, Kämpe O, Løvås K
Eur J Endocrinol.175, R107-116, 2016.

Simunkova K, Husebye ES. 
Front Horm Res. 46, 196-210, 2016.

 
Mitchell AL, Bøe Wolff A, MacArthur K, Weaver JU, Vaidya B, Swedish Addison Registry Study Group, Erichsen MM, Darlay R, Husebye ES, Cordell HJ, Pearce SH.
PLoS One. 2015 Jun 4;10(6):e0123550

Fichna M, Zurawek M, Bratland E, Husebye ES, Kasperlik-Zaluska A, Czarnocka B, Januszkiewicz-Lewandowska D,Nowak J.
Autoimmunity. 2015 Mar;48(2):100-7.

Bruserud Ø, Husebye ES.  
No. 8, 5. mai 2015 Tidsskr Nor Legeforen 2015135:763-6

.
Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, Perheentupa J, Kemp EH, Fiskerstrand T, Viken MK, Weetman AP, Fleishman SJ, Banka S, Newman WG, Sewell WA, Sozaeva LS, Zayats T, Haugarvoll K, Orlova EM, Haavik J, Johansson S, Knappskog PM, Løvås K, Wolff AS, Abramson J, Husebye ES.
Immunity. 2015 Jun 16;42(6):1185-96

Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K,Nyström T, Bensing S.
Clin Endocrinol (Oxf). 2015 Jul;83(1):28-35

Edvardsen K, Bjåsøy T, Hellesen A, Breivik L, Bakke M, Husebye ES, Bratland E.
J Interferon Cytokine Res. 2015 Oct;35(10):759-70.

.
Falorni A, Bini V, Betterle C, Brozzetti A, Castaño L, Fichna M, Kämpe O, Mellgren G, Peterson P, Chen S, RönnelidJ, Seissler J, Tiberti C, Uibo R, Yu L, Lernmark A , Husebye ES.
Clin Chem Lab Med. 2015 Oct;53(11):1761-70.

.Astor MC, Løvås K, Wolff AS, Nedrebø B, Bratland E, Steen-Johnsen J, Husebye ES. 
Endocr Connect 2015 vol. 4 no. 4 215-222


Quinkler M, Dahlqvist P, Husebye ES, Kämpe O.
Eur J Intern Med. 2015 Jan;26(1):75-6.

   
Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S.
Clin Endocrinol (Oxf). 2014 Nov 17.

Fichna M, Zurawek M, Bratland E, Husebye ES, Kasperlik-Zaluska A, Czarnocka B, Januszkiewicz-Lewandowska D, Nowak J.
Autoimmunity. 2014 Oct 27:1-8. 

     
Wolff AS, Kärner J, Owe JF, Oftedal BE, Gilhus NE, Erichsen MM, Kämoe O, Meager A, Peterson P, Kisand K, Willcox N, Husebye ES. 
J Immunol. 2014 Oct 15;193(8):3880-90.

 
Dawoodji A, Chen JL, Shepherd D, Dalin F, Tarlton A, Alimohammadi M, Penna-Martinez M, Meyer G, Mitchell AL, Gan EH, Bratland E, Bensing S, Husebye ES, Pearce SH, Badenhoop K, Kämpe O, Cerundolo V.​ 
J Immunol. 2014 Sep 1;193(5):2118-26. doi: 10.4049/jimmunol.1400056. Epub 2014 Jul 25.

Short AD, Catchpole B, Boag AM, Kennedy LJ, ​Massey J, Rothwell S, Henthorn PS, Littman MP, Husebye E, Ollier B.
Vet Rec. 2014 Nov 1;175(17):430

 
Breivik L, Oftedal BE, Bøe Wolff AS, Bratland E, Orlova EM, Husebye ES.
Clin Immunol. 2014 Jul;153(1):220-7. doi: 10.1016/j.clim.2014.04.013. Epub 2014 May 2.

 
Hellesen A, Edvardsen K, Breivik L, Husebye ES, Bratland E. 
Clin Exp Immunol. 2014 Jun;176(3):351-62. doi: 10.1111/cei.12291.

Bjanesoy TE, Andreassen BK, Bratland E, Reiner A, Islam S, Husebye ES, Bakke M. 
Mol Immunol. 2014 Jun;59(2):208-16. doi: 10.1016/j.molimm.2014.02.018. Epub 2014 Mar 22.

Øksnes M, Björnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, Broman JE, Triebner K, Kämpe O, Hulting AL, Bensing S, Husebye ES, Løvås K.
J Clin Endocrinol Metab. 2014 May;99(5):1665-74. doi: 10.1210/jc.2013-4253. Epub 2014 Feb 11.

Brønstad I, Breivik L, Methlie P, Wolff AS, Bratland E, Nermoen I, Løvås K, Husebye ES. 
Endocr Connect. 2014 Apr 15;3(2):67-74. doi: 10.1530/EC-14-0032. Print 2014.

Hegvik TA, Husebye ES, Haavik J.  
Eur Child Adolesc Psychiatry. 2014 Feb;23(2):115-7. doi: 10.1007/s00787-013-0429-3. Epub 2013 May 28

Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH.  ​
J Intern Med. 2014 Feb;275(2):104-15. doi: 10.1111/joim.12162. Epub 2013 Dec 16. Review.

Mitchell AL, Macarthur KD, Gan EH, Baggott LE, Wolff AS, Skinningsrud B, Platt H, Short A, Lobell A, Kämpe O, Bensing S, Betterle C, Kasperlik-Zaluska A, Zurawek M, Fichna M, Kockum I, Nordling Eriksson G, Ekwall O, Wahlberg J, Dahlqvist P, Hulting AL, Penna-Martinez M, Meyer G, Kahles H, Badenhoop K, Hahner S, Quinkler M, Falorni A, Phipps-Green A, Merriman TR, Ollier W, Cordell HJ, Undlien D, Czarnocka B, Husebye E, Pearce SH.  
PLoS One. 2014 Mar 10;9(3):e88991. doi: 10.1371/journal.pone.0088991. eCollection 2014.​

Wolff AS, Sarkadi AK, Maródi L, Kärner J, Orlova E, Oftedal BE, Kisand K, Oláh E, Meloni A, Myhre AG, Husebye ES, Motaghedi R, Perheentupa J, Peterson P, Willcox N, Meager A.​  
J Clin Immunol. 2013 Nov;33(8):1341-8. doi: 10.1007/s10875-013-9938-6. Epub 2013 Oct 26.

Short AD, Boag A, Catchpole B, Kennedy LJ, Massey J, Rothwell S, Husebye E, Ollier B.
J Hered.​ ​2013 Nov-Dec;104(6):807-20. doi: 10.1093/jhered/est051. Epub 2013 Aug 31.​

Shum AK, Alimohammadi M, Tan CL, Cheng MH, Metzger TC, Law CS, Lwin W, Perheentupa J, Bour-Jordan H, Carel JC, Husebye ES, De Luca F, Janson C, Sargur R, Dubois N, Kajosaari M, Wolters PJ, Chapman HA, Kämpe O, Anderson MS.
​Sci Transl Med. 2013 Oct 9;5(206):206ra139. doi: 10.1126/scitranslmed.3006998.

Methlie P, Hustad SS, Kellmann R, Almås B, Erichsen MM, Husebye E, Løvås K.
Endocr Connect. 2013 Jun 14.

Hegvik TA, Husebye ES, Haavik J. 
Eur Child Adolesc Psychiatry. 2013 May 28

Massey J, Boag A, Short AD, Scholey RA, Henthorn PS, Littman MP, Husebye E, Catchpole B, Pedersen N, Mellersh CS, Ollier WE, Kennedy LJ. 
Immunogenetics. 2013 Apr;65(4):291-7. doi10.1007/s00251-013-0680-2.

Kärner J, Meager A, Laan M, Maslovskaja J, Pihlap M, Remm A, Juronen E, Wolff AS, Husebye ES, Podkrajšek KT, Bratanic N, Battelino T, Willcox N, Peterson P, Kisand K. 
Clin Exp Immunol. 2013 Mar;171(3):263-72. doi: 10.1111/cei.12024.


Methlie P, Dankel S, Myhra T, Christensen BR, Gjerde J, Fadnes D, Våge V, L Vås K, Mellgren G. 
Obesity (Silver Spring). 2013 Mar 20. doi: 10.1002/oby.20449.

Horn MA, Erichsen MM, Wolff AS, Månsson JE, Husebye ES, Tallaksen CM, Skjeldal OH.
Clin Endocrinol (Oxf). 2013 Jan 24. doi: 10.1111/cen.12159.

Bratland E, Hellesen A, Husebye ES.  
Mol Cell Endocrinol. 365, 75-83, 2013

Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH. 
J Intern Med. 2014 Feb;275(2):104-15. doi: 10.1111/joim.12162. Epub 2013 Dec 16. Review.

Bratland E, Magitta NF, Bøe Wolff AS, Ekern T, Knappskog PM, Kämpe O, Haavik J, Husebye ES.
Immunobiology. 2012 Oct 26. doi:pii: S0171-2985(12)00516-5. 10.1016/j.imbio.2012.10.006.

Husebye ES, Erichsen MM, Myhre AG, Bratke H, Jørgensen AP, Dahlqvist P, Løvås K.
Tidsskr Nor Laegeforen. 2012 okt 02;132(18):2043-2044.

Hapnes L, Willcox N, Oftedal BE, Owe JF, Gilhus NE, Meager A, Husebye ES, Wolff AS. 
J Clin Immunol, 32, 230-7, 2012.

Nermoen I, Brønstad I, Fougner KJ, Svartberg J, Oksnes M, Husebye ES, Løvås K.
Eur J Endocrinol, 167, 507-16, 2012.

Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, Furcas M, Rosatelli MC, Cao A, Congia M.
J Clin Endocrinol Metab. 97, 1114-1124, 2012.

Øksnes M, Bensing S, Hulting AL, Kämpe O, Hackemann A, Meyer G, Badenhoop K, Betterle C, Parolo A, Giordano R, Falorni A, Papierska L, Jeske W, Kasperlik-Zaluska AA, Chatterjee VK, Husebye ES, Løvås K. 
J Clin Endocrinol Metab, 97, 568-76, 2012.

        Nermoen I, Rørvik J, Holmedal SH, Hykkerud DL, Fougner KJ, Svartberg J, Husebye ES, Løvås K. 
Clin Endocrinol (Oxf). 2011 Dec;75(6):753-9. 

Hapnes L, Willcox N, Oftedal BE, Owe JF, Gilhus NE, Meager A, Husebye ES, Wolff AS. 
J Clin Immunol. 2011 Nov 30.

 
Skinningsrud B, Lie BA, Lavant E, Carlson JA, Erlich H, Akselsen HE, Gervin K, Wolff AB, Erichsen MM, Løvås K, Husebye ES, Undlien DE. 
J Clin Endocrinol Metab. 2011 Oct;96(10)

 
Oftedal BE, Kämpe O, Meager A, Ahlgren KM, Lobell A, Husebye ES, Wolff AS. 
Scand J Immunol. 2011 Sep;74(3):327-33

 
Brønstad I, Wolff AS, Løvås K, Knappskog PM, Husebye ES. 
BMC Med Genet. 2011 Aug 18;12:111

Bratland E, Husebye ES. 
Mol Cell Endocrinol. 2011 Apr 10;336(1-2):180-90. Epub 2010 Dec 15. Review.

Smith CJ, Oscarson M, Rönnblom L, Alimohammadi M, Perheentupa J, Husebye ES, Gustafsson J, Nordmark G, Meloni A, Crock PA, Kämpe O, Bensing S.
Scand J Immunol. 2011 Feb;73(2):147-53.

 
Husebye ES, Kämpe O. 
Immunoendocrinology, pp 115-128, 2010, George S. Eisenbarth (ed.). Springer Verlag 2011.

.
Methlie P, Husebye ES, Hustad S, Lien EA, Løvås K. 
Eur J Endocrinol, 165, 761-9, 2011.

Brønstad I, Wolff AS, Lovas K, Knappskog PM, Husebye ES. 
BMC Med Genet, 12, 111-115.

Skinningsrud B, Lie BA, Lavant E, Carlson JA, Erlich H, Akselsen HE, Gervin K, Wolff AB, Erichsen MM, Løvås K, Husebye ES*, Undlien DE*. 
J Clin Endocrinol Metabol, 96, E1703-8, 2011.

Nermoen I, Rørvik J, Holmedal SH, Hykkerud DL, Fougner KJ, Svartberg J, Husebye ES, Løvås K. 
Clin Endocrinol 75, 753-9, 2011.

Oftedal BEV, Kämpe O, Meager A, Ahlgren K, Lobell A, Husebye ES, Wolff ASB. 
Scand J Immunol, 74, 327-333

Lima K, Abrahamsen TG, Wolff ASB, Husebye ES, Alimohammadi M, Kämpe O, Følling I.
Eur J Endocrinol 165, 345-352, 2011.

Bratland E, Husebye ES. 
Mol Cell Endocrinol 336, 180-190, 2011.

Smith CJ, Oscarson M, Rönnblom L, Alimohammadi M, Perheentupa J, Husebye ES, Gustafsson J, Nordmark G, Meloni A, Crock PA, Kämpe O, Bensing S. 
Scand J Immunol 73, 147-53, 2011

    
Erichsen MM, Husebye ES, Michelsen TM, Dahl AA, Løvås K.
J Clin Endocrinol Metab. 2010 Sep;95(9):4354-60. Epub 2010 Jul 7.

 Nermoen I, Husebye ES, Svartberg J, Løvås K.
Eur J Endocrinol. 2010 Sep;163(3):453-9. Epub 2010 Jun 15.

Wolff AS, Oftedal BE, Kisand K, Ersvaer E, Lima K, Husebye ES. 
Scand J Immunol. 2010 Jun;71(6):459-67.

.    
Sørheim JI, Husebye ES, Nedrebø BG, Svarstad E, Lind J, Boman H, Løvås K. 
Horm Res Paediatr. 2010;74(6):399-405. Epub 2010 May 26.

Husebye ES, Anderson MS.
Immunity. 2010 Apr 23;32(4):479-87. Review.PMID:20412758

Cheng MH, Fan U, Grewal N, Barnes M, Mehta A, Taylor S, Husebye ES, Murphy EJ, Anderson MS. 
N Engl J Med. 2010 Feb 25;362(8):764-6.

Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R, Ergun-Longmire B, Maclaren N, Krohn KJ, Pura M, Schalke B, Ströbel P, Leite MI, Battelino T, Husebye ES, Peterson P, Willcox N, Meager A. 
J Exp Med. 2010 Feb 15;207(2):299-308. 

Løvås K, Curran S, Oksnes M, Husebye ES, Huppert FA, Chatterjee VK.
J Clin Endocrinol Metab. 2010 Feb;95(2):545-51. Epub 2009 Dec 16.

 
Erichsen MM, Husebye ES, Michelsen TM, Dahl AA, Løvås K. 
J Clin Endocrinol Metabol, 95, 4354-4360, 2010

Sørheim JI, Husebye ES,,Nedrebø BG,Svarstad E, Lind J, Boman H, Løvås K. 
Hormone research in pædiatrics 74, 399-405, 2010.

Wolff ASB, Oftedal BEV, Kisand K, Ersvær E, Lima K, Husebye ES. 
Scand J Immunol, 71, 459-467, 2010.

Husebye ES, Anderson MS.
Immunity, 32, 479-487, 2010.

Husebye ES. 
J Clin Endocrinol Metab. 2009 Dec;94(12):4655-7.  

Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES. 
J Clin Endocrinol Metab. 2009 Dec;94(12):5117-24.

Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES. 
J Clin Endocrinol Metab. 2009 Dec;94(12):4882-90.

Mitchell AL, Cordell HJ, Soemedi R, Owen K, Skinningsrud B, Wolff AB, Ericksen M, Undlien D, Husebye E, Pearce SH.
J Clin Endocrinol Metab. 2009 Dec;94(12):5139-45.  

Tóth B, Bøe Wolff AS, Halász Z, Tar A, Szüts P, Ilyés I, Erdős M, Szegedi G, Husebye ES, Zeher M, Maródi L. 
Clin Endocrinol (Oxf). 2009 Oct 26. 

Skinningsrud B, Husebye ES, Gilfillan GD, Frengen E, Erichsen A, Gervin K, Ormerod E, Egeland T, Undlien DE. 
J Clin Endocrinol Metab. 2009 Oct;94(10):4086-93.

Skinningsrud B, Lie BA, Husebye ES, Kvien TK, Førre O, Flatø B, Stormyr A, Joner G, Njølstad PR, Egeland T, Undlien DE. 
Ann Rheum Dis. 2009 Sep 3. 

Bratland E, Bredholt G, Mellgren G, Knappskog PM, Mozes E, Husebye ES. 
J Autoimmun. 2009 Aug;33(1):58-67.

Husebye ES, Løvås K. 
Endocrinol Metab Clin North Am. 2009 Jun;38(2):389-405

Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES. 
Eur J Endocrinol. 2009 Jun;160(6):993-1002. 

Husebye ES, Perheentupa J, Rautemaa R, Kämpe O. 
J Intern Med. 2009 May;265(5):514-29.

Husebye E, Løvås K.
Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):147-57.  

Alimohammadi M, Dubois N, Sköldberg F, Hallgren A, Tardivel I, Hedstrand H, Haavik J, Husebye ES, Gustafsson J, Rorsman F, Meloni A, Janson C, Vialettes B, Kajosaari M, Egner W, Sargur R, Pontén F, Amoura Z, Grimfeld A, De Luca F, Betterle C, Perheentupa J, Kämpe O, Carel JC. 
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4396-401. 

Fetissov SO, Bensing S, Mulder J, Le Maitre E, Hulting AL, Harkany T, Ekwall O, Sköldberg F, Husebye ES, Perheentupa J, Rorsman F, Kämpe O, Hökfelt T.
J Comp Neurol. 2009 Mar 1;513(1):1-20.

Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B, Husebye ES. 
Eur J Endocrinol. 2009 Feb;160(2):233-7.  

Nermoen I, Følling I, Vegge K, Larmo A, Nedrebø BG, Husebye ES, Løvås K. 
Case Report Med. 2009;2009:916891.

Skinningsrud B, Husebye ES, Gervin K, Løvås K, Blomhoff A, Wolff AB, Kemp EH, Egeland T & Undlien DE. 
Eur J Hum Genet 2008;16: 977-982.

Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.
F Magitta N, Pura M, S Bøe Wolff A, Vanuga P, Meager A, M Knappskog P, Husebye ES. 
Eur J Endocrinol 2008; 158 (5):705-9

Kisand K, Link M, Wolff AS, Meager A, Tserel L, Org T, Murumägi A, Uibo R, Willcox N, Trebusak Podkrajsek K, Battelino T, Lobell A, Kämpe O, Lima K, Meloni A, Ergun-Longmire B, Maclaren NK, Perheentupa J, Krohn KJ, Scott HS, Husebye ES, Peterson P. 
Blood. 2008 Oct 1;112(7):2657-66.

Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, Pura M, Bøe Wolff AS, Husebye ES, Lilic D, Ryan KR, Gennery AR, Cant AJ, Abinun M, Spickett GP, Arkwright PD, Denning D, Costigan C, Dominguez M, McConnell V, Willcox N, Meager. 
J Clin Endocrinol Metab. 2008 Nov; 93 (11): 4389-97

Oftedal BE, Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, Meager A, Purushothaman R, Ten S, Husebye ES.
Clin Immunol. 2008 Oct; 129 (1); 163-9.         

Bøe Wolff AS, Oftedal B, Johansson S, Bruland O, Løvås K, Meager A, Pedersen C, Husebye ES & Knappskog PM.
Genes Immun 2008;9: 130-136.

Magitta NF, Bøe Wolff AS, Johansson S, Skinningsrud B, Lie BA, Myhr KM, Undlien DE,Joner G, Njølstad PR, Kvien TK, Førre O, Knappskog PM, Husebye ES. 
Genes Immun. 2008 Oct 23

Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Bøe Wolff A, Løvås K, Egeland T & Undlien DE.  
J Clin Endocrinol Metab 2008 Eur J Hum Genet. 2008 Aug;16(8):977-82.

Løvås K, Husebye ES.
Expert Opin Investig Drugs. 2008 Apr;17(4):497-509.

Bøe Wolff AS, Oftedal B, Johansson S, Bruland O, Løvås K, Meager A,Pedersen C, Husebye ES,Knappskog PM. 
Genes Immun. 2008 Mar;9(2):130-6. Epub 2008 Jan 17.

Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP,Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Beterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O.
N Engl J Med. 2008 Mar 6;358(10):1018-28.

Husebye ES. 
Tidsskr Nor Laegeforen. 2008 Feb 28;128(5):574.

 
Skinningsrud B, Husebye ES, Gervin K, Løvås K, Blomhoff A, Wolff AB, Kemp EH, Egeland T & Undlien DE.
Eur J Hum Genet 2008;16: 977-982.

Løvås K, Husebye ES.
Eur J Endocrinol. 2007 Jul;157(1):109-12.

Wolff AS, Myhr KM,Vedeler CA, Husebye ES. 
Scand J Immunol. 2007 Jun;65(6):555-8.                                                                                 

Sandaker PS, Husebye ES, Fondenes O, Bindoff LA. 
Acta Neurol Scand Suppl. 2007;187:64-7.

Løvas K, Husebye ES. 
Tidsskr. Nor Lægeforen. 2007 Mar 15;127(6):730-2. Review Norwegian.

Bensing S,Fetissov SO,Mulder J, Perheentupa J, Gustafsson J, Husebye ES, Oscarson M. Ekwall O, Crock PA,Hokfelt T, Hulting AK, Kampe O.
Proc Natl Acad Sci USA 2007 Jan 16;104(3);949-54. Epub 2007 Jan 10.

Bratland E, Wollf AS, Haavik J, Kampe O, Skoldberg F,Perheentpa J, Bredholt G, Knappskog PM,Husebye ES. 
Biochem Biophys Res Commun, 2007 Feb 16;353(3):692-8.Epub 2006 Dec 22.

Wolff AS,Erichsen MM,Meager A, Magitta NF,Myhre AG,Bollerslev J, Fougner K,Lima K, Knappskog PM, Husebye ES.
J Clin. Endocrinol Metab. 2007 Feb;92(2):595-603.Epub 2006 Nov 21.

Husebye ES, Bredholt G, Fridkin M, Dayan M, Zinger H, Mozes E. 
Endocrinology, 147, 2411-6, 2006.

Meager A, Visvalingam KV, Peterson P, Möll K, Murumåagi A, Krohn K, Eskelin P, Perheentupa J, Husebye ES, Kadota Y, Willcox N. 
Plos Med Jul,3(7)3, e289.

Bredholt G Storstein A, Haugen M, Krossnes B, Husebye ES, Knappskog PM, Vedeler CA.  
Scandinavian J of Immunol,  2006 64 (3):325-35.

Løvås K, Thorsen T, Husebye ES. 
J Endocrinol Invest, 2006 Sep,29(8):727-31.

Husebye ES,Bratland E, Bredholt G, Fridkin M, Dayan M, Mozes E.  
Endocrinology. 2006 May;147(5):2411-6.Epub 2006 Feb 23.

Husebye ES, Varhaug JE, Heimdal K.
Tidsskr Nor Lægeforen. 2005 Nov 3;125(21):2964-7.

Løvås K,Husebye ES. 
Lancet. 2005 Jun 11-17;365(9476):2058-61

Løvås K,Erichsen MM,Husebye ES,Fougner KJ,Svartberg J, Mella B, Myhre AG,Berg JP, Aarskog D. 
Tidsskr. Nor Lægeforen.2005 Jan 20;125(2):155-8 .

Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie AB, Undlien DE.
Pigment Cell Res.18,55-8,2005.​

.
Løvås K, Erichsen MM, Husebye ES, Fougner KJ, Svartberg J, Mella B, Myhre AG, Berg JP, Aarskog D. 
Tidsskr Nor lægeforen,125,155-8,2005.

Husebye, ES, Varhaug JE, Heimdal K.  
Tidsskr Nor Laegeforen. 2005.

Bøe AS, Bredholt G, Knappskog PM, Hjelmervik TO, Winquist O, Kämpe O, Husebye ES. 
Eur J Endocrinol. 150,49-56,2004

Söderbergh A,M yhre AG, Mietinen A, Eskelin P, Ekwall O, Halonen M,Hedstrand H,Nilsson T,Landgren E,Tuomi T,Gustafsson J,Husebye ES, Perheentupa J, Manns MP, Kämpe O, Rorsman F. 
J Clin Endocrinol Metabo 89,557-62,2004.

Storstein A, Monstad SE, Nakkestad Hl, Husebye ES, Vedeler CA.
J Neurology,251,197-203,2004.

Kvistad PH, Lovas K, Boman H, Myking OL. 
Eur J Endocrinol.2004 Apr;150(4):425-30

Sköldberg F, Rorsman F, Perheentupe J, Landin-Olson M, Husebye ES, Gustafsson J, Kämpe O. 
J Clin Endocrinol Metabol, 89,1636-40,2004.

Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Husebye ES, Undlien DE. 
J Clin Endocrinol Metabol, 89, 3474-3476, 2004.

Myhre AG, Stray-Pedersen A, Spangen S, Eide E, Veimo D, Knappskog PM, Abrahamsen TG, Husebye ES. 
Eur J Pediatr, 163, 604-611, 2004.

Løvås K, Cooper JG, Thorsen T, Thordarson H, Husebye ES. 
Tidsskr Nor lægeforen, 123, 1858-1859, 2003.

 
Løvås K, Husebye ES. 
Curr Opinion Pharmacotherapy 4, 2145-2149, 2003.

Cushing syndrom. I Livsboka, En bok om Addison, Adrenogenitalt Syndrom, Akromegali Cushing og hypofysesvikt
Husebye ES.
Morbus Addison foreningen 2003, pp 49-56.

Løvås K, Gebre-Medhin G, Trovik T, Fougner K, Uhlving S, Nedrebø BG, Myking OL, Kämpe O, Husebye ES. 
J Clin Endocrinical Metabol,88,1112-1118,2003

Sköldberg F, Portela-Gomes GM, Grimelius L, Nilsson G, Perheentupa J, BetterleC, Husebye ES, Gustafsson J, Rønnblom A, Rorsman F, Kämpe O. 
J Clin Endocrinol Metabol,88,1445-1452,2003.

Løvås K,Husebye ES,Holsten F, Bjorvatn B. 
Eur J Endocrinol 148,449-456,2003

Myhre AG, Årsethøy H, Undlien DE, Hovdenak N, Aksnes L, Husebye ES. 
Scand J Gastroenterol,38, 511-515, 2003.

Myhre AG, Undlien DE, Løvås K, Uhlving S, Nedrebø, BG, Fougner K, Trovik T, Sørheim JI, Husebye ES.  
J Clin Endocrinol Metabol, 87, 618-623, 2002.

Nedrebø BG,Holm P,Ulving S, Sørheim JI, Skeie S, Eide GE, Husbye ES,Lien EA, Aanderud S. 
Eur J Endocrinol, 147,583-589.2002.

Bøe AS, Knappskog PM, Myhre AG, Sørheim JI, Husebye ES. 
Eur J Endocrinol, 146, 519-522, 2002.

Løvås K, Loge JH, Husebye ES.
Clin Endocrinol, in press, 56, 581-588, 2002.

Nesje LB,Varhaug JE,Husebye ES, Ødegaard S. 
Scand J Gastroenterolo,37,732-737,2002

Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kämpe O, Rorsman F, Peltonen L, Partanen J. 
J Clin Endokrinol Metabol,87 2568-2574,2002

Myhre AG, Undlien DE, Løvås K, Uhlving S, Nedrebø, BG, Fougner K, Trovik T, Sørheim JI, Husebye ES. 
J Clin Endocrinol Metabol, 87, 618-623, 2002

Husebye ES.  
Tidsskr Nor Lægeforen, 121,1260, 2001.

Myhre AG, Halonen M, Ekwall O, Eskelin P, Hedstrand HH, Kämpe O, Rorsman F, Husebye ES. 
Clinical Endocrinology 54, 211-217, 2001.

Hedstrand H, Ekwall O, Olsson MJ, Landgren E, Kemp EH, Weetman AP, Perheentupa J, Husebye ES, Gustafsson J, Betterle C, Kämpe O, and Rorsman R. 
J Biol Chem, 276, 35390-35395, 2001.

Astuti D, Latif F, Dallol A, Dahia A, Douglas F, George E, Sköldberg F, Husebye ES, Eng C,  Maher ER. 
Am J Hum Genetics, 69, 49-54, 2001.

Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kampe O. 
Biochem Biophys Res Commun, 267, 456-61, 2000.

Gebre-Medhin, Husebye ES, Mallmin H, Helström L, Berne C, Karlsson FA, Kämpe O. 
Clin Endocrinol, 52, 775-780, 2000.

 
Husebye ES, Bøe A, Rorsman F, Kämpe O, Aakvaag A, Rygh T, Flatmark T, Haavik J. 
Clin Exp Immunology 120, 420-423, 2000.

Ekwall O, Hedstrand HH, Haavik J, Perheentupa J, Betterle C, Gustafsson J, Husebye ES, Kämpe O, Rorsman F. 
J Clin Endocrinol Metabol, 85, 2944-2950, 2000.

Søderbergh A, Rorsman F, Björses P, Ekwall O, Rygh T, Kämpe O and Husebye ES. 
J Clin Endocrinol Metabol 85, 460-463, 2000.

Hedstrand H, Peerhentupa J, Ekwall E, Gustafson J, Nordlind K, Michaëlsson G, Husebye ES, Frosman F, Kämpe O.  
J Invest Dermatol 113, 1054-8, 1999.

Ekwall O, Hedstrand HH, Grimelius L, Haavik J, Perheentupa J, Gustafsson J, Husebye ES, Kämpe O, Rorsman F.  
The Lancet, 352, 279-283, 1998

Kemp E, Ajjan RA, Husebye ES, Peterson P, Uibo, R, Imrie H, Pearce S, Watson PF, Weetman AP. 
Clin Endocrinol, 49, 609-614, 1998.

Myhre A-G, Bjørses P, Dalen A, Husebye ES.
J Clin Endocrinol Metabol, 83, 4204-4206, 1998.

 
Husebye ES, Aanderud S. 
Tidsskr Nor Lægefor, 118, 542-544, 1998.

Autoimmune polyendokrine syndrom.
Husebye ES.
Pediatrisk endokrinologi,11, 40-44, 1998.​​

 
Husebye ES, Gebre-Medhin G, Tuomi T, Perheentupa J, Landin-Olsson M, Gustafsson J, Rorsman F and Kämpe O. 
J Clin Endocrinol Metabol, 82, 147-150, 1997.